The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 10, 2021
Filed:
Mar. 25, 2015
Applicant:
Piramal Enterprises Limited, Mumbai, IN;
Inventors:
Rajiv Sharma, Fremont, CA (US);
Bichismita Sahu, Mumbai, IN;
Sunil Vasantrao Mali, Nasik, IN;
Deepak Singh, Mumbai, IN;
Pramod Bhaskar Kumar, Mumbai, IN;
Mahesh Dawange, Mumbai, IN;
Hitesh Mistry, Mumbai, IN;
Assignee:
PIRAMAL ENTERPRISES LIMITED, Mumbai, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 317/32 (2006.01); C07D 311/22 (2006.01); C07D 335/06 (2006.01); C07D 265/36 (2006.01); C07D 207/27 (2006.01); C07D 295/26 (2006.01); C07C 233/29 (2006.01); C07C 237/22 (2006.01); A61K 31/18 (2006.01); A61K 31/351 (2006.01); C07C 217/88 (2006.01); C07C 317/24 (2006.01); C07C 311/08 (2006.01); C07C 255/46 (2006.01); C07C 233/54 (2006.01); C07C 217/48 (2006.01); C07C 211/45 (2006.01); C07C 215/70 (2006.01); C07C 255/50 (2006.01); A61K 31/277 (2006.01); C07C 309/89 (2006.01); C07C 225/22 (2006.01); C07C 229/42 (2006.01); C07C 317/44 (2006.01); A61K 31/165 (2006.01); C07C 323/09 (2006.01); A61K 31/5375 (2006.01); C07C 311/37 (2006.01); C07F 5/02 (2006.01); A61K 31/402 (2006.01); C07D 317/72 (2006.01); C07C 217/76 (2006.01); C07C 205/36 (2006.01); A61K 31/382 (2006.01); C07F 7/18 (2006.01); C07C 237/52 (2006.01); C07C 311/21 (2006.01); C07C 381/10 (2006.01); C07D 211/14 (2006.01); C07D 213/30 (2006.01); C07D 231/12 (2006.01); C07D 233/58 (2006.01); C07D 257/04 (2006.01); C07D 295/088 (2006.01); C07D 295/135 (2006.01); C07D 295/192 (2006.01); C07D 305/08 (2006.01);
U.S. Cl.
CPC ...
C07C 317/32 (2013.01); A61K 31/165 (2013.01); A61K 31/18 (2013.01); A61K 31/277 (2013.01); A61K 31/351 (2013.01); A61K 31/382 (2013.01); A61K 31/402 (2013.01); A61K 31/5375 (2013.01); C07C 205/36 (2013.01); C07C 211/45 (2013.01); C07C 215/70 (2013.01); C07C 217/48 (2013.01); C07C 217/76 (2013.01); C07C 217/88 (2013.01); C07C 225/22 (2013.01); C07C 229/42 (2013.01); C07C 233/29 (2013.01); C07C 233/54 (2013.01); C07C 237/22 (2013.01); C07C 237/52 (2013.01); C07C 255/46 (2013.01); C07C 255/50 (2013.01); C07C 309/89 (2013.01); C07C 311/08 (2013.01); C07C 311/21 (2013.01); C07C 311/37 (2013.01); C07C 317/24 (2013.01); C07C 317/44 (2013.01); C07C 323/09 (2013.01); C07C 381/10 (2013.01); C07D 207/27 (2013.01); C07D 211/14 (2013.01); C07D 213/30 (2013.01); C07D 231/12 (2013.01); C07D 233/58 (2013.01); C07D 257/04 (2013.01); C07D 265/36 (2013.01); C07D 295/088 (2013.01); C07D 295/135 (2013.01); C07D 295/192 (2013.01); C07D 295/26 (2013.01); C07D 305/08 (2013.01); C07D 311/22 (2013.01); C07D 317/72 (2013.01); C07D 335/06 (2013.01); C07F 5/025 (2013.01); C07F 7/1804 (2013.01); C07C 2601/02 (2017.05); C07C 2601/04 (2017.05); C07C 2601/08 (2017.05); C07C 2601/14 (2017.05); C07C 2602/10 (2017.05);
Abstract
The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparation. The invention further relates to pharmaceutical compositions containing the compounds and their use in the treatment of diseases or disorders mediated by RORγ.